Your browser doesn't support javascript.
loading
Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer.
Liu, Li; Bai, Xue; Wang, Jian; Tang, Xin-Ran; Wu, De-Hua; Du, Sha-Sha; Du, Xiu-Ju; Zhang, Yao-Wei; Zhu, Hong-Bo; Fang, Yuan; Guo, Ze-Qin; Zeng, Qin; Guo, Xue-Jun; Liu, Zhu; Dong, Zhong-Yi.
Afiliación
  • Liu L; Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Bai X; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Wang J; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Tang XR; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Wu DH; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Du SS; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Du XJ; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang YW; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhu HB; Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Fang Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Guo ZQ; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zeng Q; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Guo XJ; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Liu Z; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Dong ZY; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. dongzy1317@foxmail.com.
Clin Cancer Res ; 25(24): 7413-7423, 2019 12 15.
Article en En | MEDLINE | ID: mdl-31515453
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Variaciones en el Número de Copia de ADN / Inmunoterapia / Mutación / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Variaciones en el Número de Copia de ADN / Inmunoterapia / Mutación / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos